6Susa M,Hacker J,Marre R,et al.De novo synthesis of Legionella pneumophila antigens during intracellular growth in phagocytic cells[J].Infect Immun,1996,64(5):1679-1684. 被引量：1
5Jonas D, Rosenbaum A, Weyrich S, et al. Enzyme-linked imm unoassay for detection of PCR-amplified DNA of legionellae in brochoalveolar fluid. J Clin Microbiol, 1995,33:1247～1252 被引量：1
6Matsioto-Bernard P, Piksouni E, Legakis N, et al. Evaluati on of commercial amplification kit for detection legionella pneumophila in clini cal samples. J Clin Microbiol, 1994,32:1502～1505 被引量：1
7Pedersen S W. Pulmonary legionella infection with CNS manif estations. Ugeskr Lageger, 1998,160:286～287 被引量：1
8Edelstein P H. Legionnaires'disease. Clin Infect Dis, 1993, 16:741～749 被引量：1
4Brown RB. Legionella pneumonia : the spectrum continues to expand. Chest ,2004,125 : 1979-1980. 被引量：1
5Niederman MS, Mandell LA, Anzueto A, et al ; American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy,and prevention. Am J Respir Crit Care Med, 2001,165: 1730-1754. 被引量：1
6Roig J, Rello J. Legionnaires' disease :a rational approach to therapy. J Antimicrob Chemother, 2003,51 : 1119 -1129. 被引量：1
7Byrd RP Jr, Fields CL, Roy TM. Prognostic factors in Legionnaiella pneumonia. Am J Respir Crit Care Med, 1999,159:342. 被引量：1
8Benson RF, Fields BS. Classification of the genus Legionella. Semin Respir Infect, 1998,13:90-99. 被引量：1
9Blazquez Garrido RM, Espinosa Parra FJ, Alemany Frances L, et al. Antimicrobial chemotherapy for Legionnaires disease:levofloxacin versus macrolides. Clin Infect Dis,2005,41:416-417. 被引量：1
